Nine out of 10 Medicare patients who received a stent procedure for coronary disease report that their physicians did not present them with the non-invasive alternative of managing their condition with medication, according to the results of a study published online today by the Journal of General Internal Medicine. Floyd J. Fowler Jr., senior scientific advisor at the Informed Medical Decisions Foundation, was the study's principal investigator.
Posted in Current News
Tagged coronary artery disease, coronary artery disease treatment, decision support, heart disease, patient-centered care, patients, prostate cancer, prostate cancer treatment, prostate surgery, shared decision making, stenting, stents
Prostate cancer screening and treatment made the news again this week with Warren Buffett’s announcement that he has early stage, localized, prostate cancer identified through the use of a PSA screening test. The 81 year-old Buffett is six years older than the recommended cut off age for regular PSA testing. He has opted for two months of radiation to treat the cancer. Both Buffett’s diagnosis and treatment choice has put the spotlight on a diagnostic tool and disease that is poorly understood by many people.
The proposed study will examine predictors of informed decision making in men considering treatment for localized prostate cancer. Specifically, we will evaluate the ability of functional health literacy and cancer-related anxiety to predict indices of effective decision making in a population of veterans with prostate cancer. Measure of prostate cancer knowledge, decisional conflict, and eventual treatment choice will be used to assess these three components of effective decisions.
Prostate cancer progresses at different rates for different men. Therefore the best time to start hormone therapy is not the same for everyone. To help men decide if and when hormone therapy is right for them, the Informed Medical Decisions Foundation has developed a Shared Decision-Making® program called Hormone Therapy: When the PSA Rises after Prostate Cancer Treatment.
Most prostate cancers that are discovered after a PSA test are early-stage cancers. But not all early-stage cancers are the same. To understand how much treatment may help, it's important for men to understand whether their cancer is high or low risk. Then they can balance the benefit of treatment against the possible side effects. To help men make a good treatment decision, the Foundation has developed a Shared Decision-Making® program called Treatment Choices for Localized Prostate Cancer.